• 1
    Duell EJ,Wiencke JK,Cheng T-J,Varkonyi A,Zou Z,Ashok T,Mark E,Wain J,Christiani D,Kelsey K. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 96571.
  • 2
    Shen J,Desai M,Agrawal MK,Kennedy DO,Senie RT,Santella RM,Terry MB. Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 161419.
  • 3
    Mechanic LE,Millikan RC,Player J,de Cotret AR,Winkel S,Worley K,Heard K,Tse C-K,Keku T. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 2006; 27: 137785.
  • 4
    Kumar R,Hoglund L,Zhao C,Forsti A,Snellman E,Hemminki K. Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer 2003; 103: 6715.
  • 5
    McLuckie KI,Crookston RJ,Gaskell M,Farmer PB,Routledge MN,Martin EA,Brown K. Mutation spectra induced by α-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells. Biochem 2005; 44: 8198205.
  • 6
    Brewster AM,Helzlsouer KJ,Huang HY,Lunn R,Hoffman S,Bell D. The association between polymorphisms in the xeroderma pigmentosum group D gene and risk of breast cancer. Am J Epidemiol 2001; 153( 11 Suppl): S198.
  • 7
    Amirimani B,Rebbeck TR,Weber BL. Role of polymorphisms in XRCC1 and XPD as breast cancer risk modifiers in BRCA1 mutation carriers. Proc Am Assoc Cancer Res 2001; 42: 3228.
  • 8
    Terry MB,Gammon MD,Zhang FF,Eng SM,Sagiv SK,Paykin AB,Wang Q,Hayes S,Teitelbaum SL,Neugut AI,Santella RM. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 20538.
  • 9
    Cheng L,Guan Y,Li L,Legerski RJ,Einspahr J,Bangert J,Alberts DS,Wei Q. Expression in normal tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 1999; 8: 8017.
  • 10
    Sugasawa K,Ng JMY,Masutani C,Iwai S,van der Spek PJ,Eker APM,Hanaoka F,Bootsma D,Hoeijmakers JHJ. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998; 2: 22332.
  • 11
    Wijnhoven SW,Kool HJ,Mullenders LH,van Zeeland AA,Friedberg EC,van der Horst GT,van Steeg H,Vrieling H. Age-dependent spontaneous mutagenesis in Xpc mice defective in nucleotide excision repair. Oncogene 2000; 19: 50347.
  • 12
    Ananthaswamy HN,Ouhtit A,Evans RL,Gorny A,Khaskina P,Sands AT,Conti CJ. Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis. Oncogene 1999; 18: 73958.
  • 13
    Cheo DL,Burns DK,Meira LB,Houle JF,Friedberg EC. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53−/− mice. Cancer Res 1999; 59: 7715.
  • 14
    Friedberg EC,Bond JP,Burns DK,Cheo DL,Greenblatt MS,Meira LB,Nahari D,Reis AM. Defective nucleotide excision repair in Xpc mutant mice and its association with cancer predisposition. Mutat Res 2000; 459: 99108.
  • 15
    Khan SG,Metter EJ,Tarone RE,Bohr VA,Grossman L,Hedayati M,Bale SJ,Emmert S,Kraemer KH. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis 2000; 21: 18215.
  • 16
    Khan SG,Muniz-Medina V,Shahlavi T,Baker CC,Inui H,Ueda T,Emmert S,Schneider TD,Kraemer KH. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucl Acids Res 2002; 30: 362431.
  • 17
    Marin MS,Lopez-Cima MF,Garcia-Castro L,Pascual T,Marron MG,Tardon A. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 178893.
  • 18
    Vodicka P,Kumar R,Stetina R,Sanyal S,Soucek P,Haufroid V,Dusinska M,Kuricova M,Zamecnikova M,Musak L,Buchancova J,Norppa H, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004; 25: 75763.
  • 19
    Qiao Y,Spitz MR,Shen H,Guo Z,Shete S,Hedayati M,Grossman L,Mohrenweiser H,Wei Q. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002; 23: 2959.
  • 20
    Lin J,Swan GE,Shields PG,Benowitz NL,Gu J,Amos CI,de Andrade M,Spitz MR,Wu X. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 2007; 16: 206571.
  • 21
    Vogel U,Dybdahl M,Frentz G,Nexo BA. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat Res 2000; 461: 197210.
  • 22
    Matullo G,Palli D,Peluso M,Guarrera S,Carturan S,Celentano E,Krogh V,Munnia A,Tumino R,Polidoro S,Piazza A,Vineis P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001; 22: 143745.
  • 23
    Tang D,Cho S,Rundle A,Chen S,Phillips D,Zhou J,Hsu Y,Schnabel F,Estabrook A,Perera FP. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 2002; 75: 15966.
  • 24
    Hou S-M,Falt S,Angelini S,Yang K,Nyberg F,Lambert B,Hemminki K. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002; 23: 599603.
  • 25
    Spitz MR,Wu X,Wang Y,Wang L-E,Shete S,Amos CI,Guo Z,Lei L,Mohrenweiser H,Wei Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61: 13547.
  • 26
    Hu Z,Wei Q,Wang X,Shen H. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 2004; 46: 110.
  • 27
    Sturgis EM,Zheng R,Castillo EJ,Eicher SA,Strom SS,Spitz MR,Wei Q. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000; 2: 221923.
  • 28
    Vogel U,Hedayati M,Dybdahl M,Grossman L,Nexo BA. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 2001; 22: 899904.
  • 29
    Winsey SL,Haldar NA,Marsh HP,Bunce M,Marshall SE,Harris AL,Wojnarowska F,Welsh KI. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000; 60: 561216.
  • 30
    Zeleniuch-Jacquotte A,Shore RE,Koenig KL,Akhmedkhanov A,Afanasyeva Y,Kato I,Kim MY,Rinaldi S,Kaaks R,Toniolo P. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 2004; 90: 1539.
  • 31
    Kato I,Toniolo P,Koenig KL,Kahn A,Schymura M,Zeleniuch-Jacquotte A. Comparison of active and cancer registry-based follow-up for breast cancer in a prospective cohort study. Am J Epidemiol 1999; 149: 3728.
  • 32
    David-Beabes GL,Lunn RM,London SJ. No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 91112.
  • 33
    Shen H,Sturgis EM,Khan SG,Qiao Y,Shahlavi T,Eicher SA,Xu Y,Wang X,Strom SS,Spitz MR,Kraemer KH,Wei Q. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res 2001; 61: 33215.
  • 34
    Blankenburg S,Konig IR,Moessner R,Laspe P,Thoms K-M,Krueger U,Khan SG,Westphal G,Berking C,Volkenandt M,Reich K,Neumann C, et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 2005; 26: 108590.
  • 35
    Zhu Y,Lai M,Yang H,Lin J,Huang M,Grossman HB,Dinney CP,Wu X. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis 2007; 28: 698703.
  • 36
    Zhang L,Zhang Z,Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 2005; 359: 1505.
  • 37
    Forsti A,Angelini S,Festa F,Sanyal S,Zhang Z,Grzybowska E,Pamula J,Pekala W,Zientek H,Hemminki K,Kumar R. Single nucleotide polymorphisms in breast cancer. Oncol Rep 2004; 11: 91722.
  • 38
    Jorgensen TJ,Visvanathan K,Ruczinski I,Thuita L,Hoffman S,Helzlsouer K. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat 2007; 101: 6571.
  • 39
    Sak SC,Barrett JH,Paul AB,Bishop DT,Kiltie AE. The polyAT, intronic IVSII-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer 2005; 92: 22625.
  • 40
    Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 1999; 424: 12742.
  • 41
    Sanyal S,Festa F,Sakano S,Zhang Z,Steineck G,Norming U,Wijkstrom H,Larsson P,Kumar R,Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004; 25: 72934.
  • 42
    Cheng C-W,Huang C-S,Chen J-J,Wu P-E,Wu C-W,Shen C-Y. Breast cancer risk associated with genotype polymorphism of oxidative DNA damage repair genes: a multigenic study of base excision repair and transcription-coupled repair in cancer susceptibility. Proc Am Assoc Cancer Res 2002; 43: 245.
  • 43
    Justenhoven C,Hamann U,Pesch B,Harth V,Rabstein S,Baisch C,Vollmert C,Illig T,Ko Y-D,Bruning T,Brauch H, (Interdisciplinary Study Group on Gene Environment Interactions and Breast Cancer in Germany Network). ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 2004; 13: 205964.
  • 44
    Kuschel B,Chevenix-Trench G,Spurdle AB,Chen X,Hopper JL,Giles GG,McCredie M,Chang-Claude J,Gregory CS,Day NE,Easton DF,Ponder BAJ, et al. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 182831.